CD4 and metabolic syndrome: By modeling quantiles for residual lifetimes to the onset of dyslipidemia and applying our proposed induced smoothing method, we dynamically assessed the effect of CD4 cell count, a longitudinal biomarker, for different evaluation times and quantiles.